#VisualAbstract: Camrelizumab plus gemcitabine and cisplatin improves progression-free survival in patients with recurrent or metastatic nasopharyngeal carcinoma

byTeddy Guo

August 26, 2021

in StudyGraphics

Reading Time: 1 min read

Wellness Check: Exercise

RelatedReports

#VisualAbstract: Gonadotrophin-releasing hormone analogs reduces rates of premature ovarian insufficiency in premenopausal women with breast cancer

StudyGraphics

#VisualAbstract: Nedaplatin-based concurrent chemoradiotherapy is noninferior to cisplatin for stage II-IVB nasopharyngeal carcinoma

January 19, 2022

#VisualAbstract: Acral lentiginous melanoma may be associated with higher rates of sentinel lymph node positivity compared to other melanoma subtypes

StudyGraphics

#VisualAbstract: Immune checkpoint inhibitors are equally effective for younger and older patients with relapsed or metastatic head and neck squamous cell carcinomas

January 12, 2022

#VisualAbstract: Hereditary retinoblastoma survivors are at an increased risk for melanoma and non-melanoma skin cancers

StudyGraphics

#VisualAbstract: Taxane monotherapy may be more effective for patients with recurrent or metastatic head and neck cancer and prior nivolumab exposure

January 5, 2022

#VisualAbstract: Nivolumab plus ipilimumab may be less effective in females with melanoma compared to males

StudyGraphics

#VisualAbstract: Neoadjuvant chemotherapy plus surgery improves overall survival compared to surgery alone in locally advanced esophageal cancer

December 22, 2021

#VisualAbstract: Substance use and mental health conditions in adolescents associated with future non- prescription opioid use

#VisualAbstract New RCT (JADE TEEN) shows efficacy and safety of abrocitinib in combination with topical therapy in adolescents with moderate-to-severe atopic dermatitis

Pediatric renal and thyroid cancer rates increase

Multifocal papillary thyroid carcinoma has a higher risk of recurrence than unifocal cancer

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

#VisualAbstract: Camrelizumab plus gemcitabine and cisplatin improves progression-free survival in patients with recurrent or metastatic nasopharyngeal carcinoma

#VisualAbstract: Nedaplatin-based concurrent chemoradiotherapy is noninferior to cisplatin for stage II-IVB nasopharyngeal carcinoma

#VisualAbstract: Immune checkpoint inhibitors are equally effective for younger and older patients with relapsed or metastatic head and neck squamous cell carcinomas

#VisualAbstract: Taxane monotherapy may be more effective for patients with recurrent or metastatic head and neck cancer and prior nivolumab exposure

Wellness Check: Exercise

#VisualAbstract: Substance use and mental health conditions in adolescents associated with future non- prescription opioid use

RelatedReports

#VisualAbstract: Nedaplatin-based concurrent chemoradiotherapy is noninferior to cisplatin for stage II-IVB nasopharyngeal carcinoma

#VisualAbstract: Immune checkpoint inhibitors are equally effective for younger and older patients with relapsed or metastatic head and neck squamous cell carcinomas

#VisualAbstract: Taxane monotherapy may be more effective for patients with recurrent or metastatic head and neck cancer and prior nivolumab exposure

#VisualAbstract: Neoadjuvant chemotherapy plus surgery improves overall survival compared to surgery alone in locally advanced esophageal cancer

#VisualAbstract: Substance use and mental health conditions in adolescents associated with future non- prescription opioid use

#VisualAbstract New RCT (JADE TEEN) shows efficacy and safety of abrocitinib in combination with topical therapy in adolescents with moderate-to-severe atopic dermatitis

Multifocal papillary thyroid carcinoma has a higher risk of recurrence than unifocal cancer

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

Get Full Access

Recent Reports

Welcome Back!

Create New Account!

Retrieve your password

#VisualAbstract: Camrelizumab plus gemcitabine and cisplatin improves progression-free survival in patients with recurrent or metastatic nasopharyngeal carcinoma

RELATED REPORTS

Wellness Check: Exercise

#VisualAbstract: Substance use and mental health conditions in adolescents associated with future non- prescription opioid use

RelatedReports

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

Get Full Access

Recent Reports

Welcome Back!

Create New Account!

Retrieve your password